HighTower Advisors
DFTX icon

HighTower Advisors’s Definium Therapeutics DFTX Stock Holding History

HighTower Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$937K Buy
24,619
+2,306
+10% +$97.2K ﹤0.01% 2306
2026
Q2 		$1.05M Buy
22,313
+3,754
+20% +$92.8K ﹤0.01% 2212
2026
Q1 		$351K Buy
+18,559
New +$315K ﹤0.01% 3021
2025
Q4 		– Sell
-12,643
Closed -$149K – 3850
2025
Q3 		$149K Sell
12,643
-32
-0.3% -$298 ﹤0.01% 3455
2025
Q2 		$82.3K Sell
12,675
-1
-0% -$7 ﹤0.01% 3501
2025
Q1 		$74.2K Sell
12,676
-353
-3% -$2.53K ﹤0.01% 3405
2024
Q4 		$90.7K Buy
13,029
+50
+0.4% +$344 ﹤0.01% 3393
2024
Q3 		$73K Sell
12,979
-1,551
-11% -$10.8K ﹤0.01% 3361
2024
Q2 		$104K Buy
+14,530
New +$127K ﹤0.01% 3195
2022
Q2 		– Sell
-6,998
Closed -$119K – 3433
2022
Q1 		$119K Buy
6,998
+3,049
+77% +$52.9K ﹤0.01% 2960
2021
Q4 		$81K Sell
3,949
-3,531
-47% -$113K ﹤0.01% 2959
2021
Q3 		$264K Buy
7,480
+3,648
+95% +$158K ﹤0.01% 2508
2021
Q2 		$198K Buy
+3,832
New +$201K ﹤0.01% 2675

Other funds holding DFTX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

HighTower Advisors's DFTX Position: Q3 2026 in Review

HighTower Advisors increased its Definium Therapeutics (DFTX) stake by 10% in Q3 2026, buying an estimated $97.2K and bringing the position to 24,619 shares worth $937K. The position accounts for ﹤0.01% of the portfolio, ranked #2306.

HighTower Advisors first reported a position in DFTX in Q2 2021 and has held it in 13 quarters since. The position peaked at $1.05M in Q2 2026. 253 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • HighTower Advisors held 24,619 shares of Definium Therapeutics worth $937K as of Q3 2026.
  • HighTower Advisors bought 2,306 Definium Therapeutics shares in Q3 2026, an estimated $97.2K.
  • Definium Therapeutics made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #2306 holding.
  • HighTower Advisors first reported a position in Definium Therapeutics in Q2 2021 and has held it in 13 quarters since.
  • HighTower Advisors's Definium Therapeutics position peaked at $1.05M in Q2 2026.
  • 253 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.